Conferences, summits, and gatherings from across the psychedelic research community
Spin the globe — gold pins are upcoming events, pale ones are past. Click a pin to jump to its details.
Horizons is the 19th annual conference examining the potential of psychedelics in science, medicine, policy, and culture. The three-day event features industry briefings, scientific updates, and cultural dialogues presented at the New York Academy of Medicine.
An international nine-day gathering dedicated to Ketamine-Assisted Psychotherapy (KAP) bringing together clinicians, researchers and experienced practitioners for scientific exchange, clinical training and advanced experiential learning. The program includes the 1st KAP International Association Summit, an introductory clinical workshop and a post-summit residential training for experienced professionals.
The Microdosing Summit is the first summit built entirely around low-dose psychedelic use, featuring panels, presentations, and workshops spanning research, policy, culture, and practice. The event brings together leading voices, researchers, founders, and community members to discuss the potential of low-dose psychedelics across topics including creativity, athletics, women's health, and policy development.
The Vital Conference brings together practitioners, educators, clinicians, facilitators, integration workers, and students in the psychedelic field for two full days of presentations, panels, and practical frameworks. The event includes an optional two-day music training workshop on music as a core facilitation skill for expanded-state work.
The 6th Annual Conference on Psychedelics and Psychedelic Medicine is a clinically focused two-day conference examining the rapidly evolving field of psychedelic medicine and psychedelic-assisted therapies. The program features presentations and expert panels on research, mechanisms of action, clinical applications for conditions such as depression and PTSD, ethical considerations, and cultural perspectives. Both in-person and virtual attendance options are available.
A global virtual gathering that unites patients, families, clinicians, researchers, and organizations to examine emerging risks, unmet needs, and how lived experience can shape safer, more responsive care after psychedelic treatment protocols and studies end.
A documentary screening followed by a live conversation exploring mental health, mortality, caregiving and emerging approaches to end-of-life distress. The film follows Steve "Buck" Allgood, who was diagnosed with an aggressive brain tumour and pursued psilocybin-assisted psychotherapy as part of his care journey. The event features Buck, members of his care team and special guests in discussion.
The inaugural Conference for Asia-Pacific Psychedelic Science brings together leading researchers, clinicians, policymakers, and practitioners to advance psychedelic science and practice in the region. The conference features keynotes, symposia, networking events, and optional pre-conference workshops spanning research, clinical practice, policy, and ethics.
PsyCon is a psychedelic conference featuring speakers, exhibitors, and sponsors discussing the psychedelic market, industry landscape, and related topics. The event includes a pre-show crash course, main conference sessions, and an official after party for networking and community engagement.
Psychedelic Science 2027 is the flagship global gathering hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), bringing together researchers, clinicians, policymakers, advocates, and cultural leaders to explore psychedelic research, therapy, and policy. The five-day event features expert panels, keynote presentations, workshops, networking opportunities, and community events centered on the theme 'Bridging Promise & Practice'.
The Harm Reduction International Conference is a biennial global gathering that brings together over 1,000 delegates including health workers, academics, researchers, policy makers, and people who use drugs to discuss the latest research, innovations, and advocacy in harm reduction and drug policy. The conference features presentations, workshops, films, and networking events focused on best practices in drug use, harm reduction, and human rights.
Beyond Wonderland is a two-day immersive conference focused on psychedelic science, consciousness technology, and human performance. The event brings together 60+ world-class speakers, 50+ exhibitors, and 600+ attendees including clinicians, therapists, researchers, entrepreneurs, and policy makers for talks, experiential sessions, networking, and a tech hall showcasing cutting-edge wellness tools.
A gathering bringing together ancestral voices, communities, researchers, practitioners, artists, and allies from across the globe to explore topics such as ethics, safety, and integration of ayahuasca through Indigenous leadership and intercultural dialogue. The forum features five days of deep listening, learning, and cultural exchange woven with music, dance, visual arts, and living traditions.
The Oregon Psychedelic Innovation Summit examines breakthroughs and real-world outcomes from Oregon's regulated psilocybin therapy program, which has served over 22,000 people. The event brings together OHSU leadership, researchers, policymakers, and practitioners to discuss clinical findings and chart the future direction of Oregon's psilocybin ecosystem, followed by a reception and cocktail hour.
An intimate screening of The Next Chapter, a documentary about psilocybin-assisted therapy and healing in the second half of life, followed by a live panel Q&A with filmmaker Scott Paul Wright and experts in mental health, medicine, and lived experience.
An intimate screening of The Next Chapter, a documentary about psilocybin-assisted therapy and healing in the second half of life, followed by a live panel discussion with filmmaker Scott Paul Wright and experts in mental health, medicine, and psychedelic-assisted therapy. About the Film The Next Chapter follows a group of people navigating the second half of life who refused to accept that their best days were behind them. Carrying the weight of depression, anxiety, grief, and long-unresolved pain, they stepped into the world of psilocybin-assisted therapy in search of something they had nearly stopped believing in: the possibility of healing. This is not a film about a treatment. It is a deeply personal story about courage, vulnerability, and what it means to begin again. The Evening 🎬 Doors open: 6:00pm 📽️ Screening: 7:00pm (~45 minutes) 🎤 Panel Q&A: immediately following 📍 VIU Theatre, Building 356, Room 109, 900 Fifth Street, Nanaimo, BC Meet the Panelists Scott Paul Wright — Filmmaker, The Next Chapter Scott Paul Wright is a filmmaker, writer, and producer whose work has consistently explored the human story behind larger subjects. With The Next Chapter, the subject is also personal — Wright came to psilocybin through his own experience at 68, reflecting the life stage of many of the people featured in the film. He joins us live for this Vancouver premiere. Kenneth Tupper — Ph.D., Public Health Policy Consultant, Educator Kenneth Tupper, Ph.D., is a public health policy consultant, scholar, educator, and host of the podcast Intonicated. An Adjunct Professor with both the University of British Columbia and University of Victoria, as well as former senior leader with the BC Ministry of Health, his work explores how psychedelics can foster learning, healing, and human flourishing across the lifespan. Drawing on decades of policy experience and his research on entheogenic education, Kenneth offers a thoughtful voice on why many older adults are turning to psychedelics to heal long-held childhood trauma, family conditioning, and patterns that no longer serve them. He recently co-authored a paper examining the emerging intersection of psychedelics and longevity science. More information about Kenneth is available at https://kennethtupper.ca/ Wes Taylor (Moderator) — Psychotherapist, Educator Wes Taylor is a psychotherapist, educator, and leader with more than four decades of experience in healing and professional development. A foundational member of the Roots to Thrive team, he helps lead RTT’s Professional Experiential Training program, supporting the development of psychedelic-assisted therapy practitioners. Wes was an instructor in Vancouver Island University’s Psychedelic-assisted Therapy Graduate Certificate program and has contributed to the advancement of experiential psychedelic training in Canada. Drawing on extensive experience in trauma recovery, addiction treatment, and transformational learning, he is committed to fostering ethical, relational, and evidence-informed psychedelic care and practitioner development. Respectfully living on unceded Snuneymuxw territory, Wes is also serving as Director of AVI Health and Community Services. Helen Watler — Energy Practitioner, EFT Practitioner Helen is an Eden Method Advanced Practitioner, and an Accredited Advanced EFT (Emotional Freedom Techniques/Tapping) Practitioner. She maintains a private practice and serves as an Energy Practitioner with Roots to Thrive, where energy medicine is integrated into psychedelic-assisted therapy programs. Through her work, Helen has supported clients in addressing trauma, emotional dysregulation, and long-held behavioral patterns. She has witnessed significant transformation in participants engaged in psychedelic-assisted healing and is inspired by the boldness and courage of older adults participating in this work. Helen loves this work for its ability to increase our capacity to hold consciousness. Presented by the Psychedelic Association of Canada in partnership with MAPS Canada, Roots to Thrive & Qi Integrated Health, Therapsil, & The Flying Sage PAC is a national organization advancing ethical, evidence-based psychedelic practice and equitable access in Canada. Learn more at psychedelicassociation.net
A screening of the documentary The Next Chapter about psilocybin-assisted therapy and healing in the second half of life, followed by a live panel Q&A with filmmaker Scott Paul Wright and mental health advocates exploring the intersection of medicine and lived experience.
ICPR 2026 is the 7th edition of Europe's premier interdisciplinary conference on psychedelic research, bringing together academics, researchers, clinicians, therapists, policymakers, and members of the public. The conference features keynote talks, posters, panels, themed symposia, networking events, and workshops focused on the science, practice, and policy of psychedelics.
This webinar features analyst Josh Hardman, Founder and Editor of Psychedelic Alpha, providing an update on the current state of the psychedelic medicines field. Drawing on his work tracking psychedelic drug development and policy globally, Hardman surveys recent investment trends, the clinical pipeline, lobbying activity, public perception, and international access models, with case studies from Australia, Czechia, Germany, Norway, and Canada.
